Blackkeel, explained

About

Blackkeel is an independent resource on ibogaine harm reduction, focused on clear risk context, screening considerations, and informed decision-making. It prioritizes safety, uncertainty, and accountability over therapeutic promises.

We exist because decisions are better served by careful questions than by certainty. Our main resource is built for people considering or affected by ibogaine, alongside families, support networks, and harm-reduction-minded professionals.

Hands held in a quiet conversation, reflecting Blackkeel's careful, people-centered approach

Our position Safety before promise.

Our editorial approach

Clear boundaries make clearer information.

Blackkeel organizes material around practical decision points, uncertainty, and the limits of what a resource can responsibly say. We draw on registries, published literature, official sources, and established reference material, while distinguishing context from advice. The ClinicalTrials.gov study registry is one example of the public record that can help readers locate research without turning a listing into a recommendation.

Safety before promise
Evidence awareness
Informed consent
Plain language
Accountability

Open natural landscape suggesting room for reflection and careful choices

What we cover

A structure for navigating difficult questions.

Information is organized to help readers identify what needs closer attention, what remains uncertain, and where independent verification matters. Our resource pathways make that structure easier to follow without presenting a treatment pathway or a clinical service.

When a topic touches on research language, we use sources such as the National Center for Biotechnology Information to ground terms and literature access in a traceable public record. That does not make Blackkeel a medical authority; it supports a transparent method for checking claims.

We do not use certainty as a substitute for evidence, and we do not present information as personal medical or legal guidance.

Who this is for

For people who need language for the decision around them.

Blackkeel is for people considering or affected by ibogaine, as well as families, support networks, and professionals approaching the subject through a harm-reduction lens. The aim is not to direct anyone toward an outcome, but to make room for more deliberate conversations.

Readers may encounter different framings elsewhere, including discussion of ibogaine neuroplasticity and claims about neuroregeneration. Blackkeel treats those topics as prompts for source-checking and context, not as proof of a promised result.

We also recognize that personal interpretation can shape how people describe experience. References to an ibogaine and ego perspective or an ibogaine spiritual reset belong to a wider conversation, while Blackkeel remains focused on clarity, limits, and accountability.

“Independent by design means keeping the boundary between information and instruction visible.”
Blackkeel editorial principle

Independent by design

Information is not a substitute for care.

Blackkeel is an independent editorial resource, not a clinic, medical provider, licensed treatment center, or legal authority. It does not provide medical or legal advice. Claims around an ibogaine alternative, treatment for alcoholism, or whether ibogaine works for alcohol deserve careful scrutiny rather than a simple conclusion.

Review the safety checklist